| P50 | author | Selma Regina De Oliveira Raymundo | Q88833060 |
| P2093 | author name string | Suzana Margareth Ajeje Lobo | |
| | Isabela Tobal Secches | |
| | Kassim Guzzon Hussein | |
| | Kassim Mohamede Kassim Hussain | |
| P2860 | cites work | Prolonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgery | Q24241736 |
| | A computerized reminder system to increase the use of preventive care for hospitalized patients | Q28189511 |
| | Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach | Q28211525 |
| | Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q28284893 |
| | Physician compliance with advanced electronic alerts for preventing venous thromboembolism among hospitalized medical patients | Q33384984 |
| | Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thrombo-embolism in high-risk patients | Q33402068 |
| | Effect of point-of-care computer reminders on physician behaviour: a systematic review | Q33743514 |
| | A clinical decision support system for venous thromboembolism prophylaxis at a general hospital in a middle-income country | Q33823987 |
| | Apixaban or enoxaparin for thromboprophylaxis after knee replacement | Q34018819 |
| | Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial | Q34102430 |
| | The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians | Q34131079 |
| | Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. | Q51759037 |
| | Venous thromboembolism: a public health concern. | Q51911735 |
| | Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q53040204 |
| | The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. | Q53229008 |
| | Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. | Q55051305 |
| | Sabemos prescrever profilaxia de tromboembolismo venoso nos pacientes internados? | Q55345178 |
| | A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients | Q57311991 |
| | Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial | Q57651026 |
| | The AVAIL ME Extension: a multinational Middle Eastern survey of venous thromboembolism risk and prophylaxis | Q57998269 |
| | Dabigatran etexilate for prevention of venous thromboembolism | Q58375704 |
| | The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison | Q59651031 |
| | Prevention of venous thrombosis and pulmonary embolism | Q68897032 |
| | ACCP-NHLBI National Conference on Antithrombotic Therapy. American College of Chest Physicians and the National Heart, Lung and Blood Institute | Q69995039 |
| | Risk factors for venous thromboembolism | Q73548120 |
| | Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur | Q78915259 |
| | [Inadequacy of thromboprophylaxis in hospitalized medical patients] | Q79623880 |
| | [Guidelines for pulmonary embolism] | Q80451586 |
| | New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q81509037 |
| | Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study | Q83943627 |
| | [Impact of a program for venous thromboembolism prophylaxis in hospitalized patients in four hospitals in Salvador] | Q84293050 |
| | Thrombosis prophylaxis and mortality risk among critically ill adults | Q87659945 |
| | Incidence of deep vein thrombosis and quality of venous thromboembolism prophylaxis | Q87764145 |
| | Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial | Q34343613 |
| | Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis | Q34473966 |
| | Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery | Q34561015 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial | Q34607209 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty | Q34789112 |
| | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty | Q34789118 |
| | Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial | Q34789474 |
| | Managing venous thromboembolism in Latin American patients: emerging results from the Brazilian Registry | Q34859612 |
| | Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol | Q34959822 |
| | Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752562 |
| | Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752615 |
| | A preliminary assessment of the critical differences between novel oral anticoagulants currently in development | Q36229356 |
| | The epidemiology of venous thromboembolism in the community: implications for prevention and management | Q36395263 |
| | Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome | Q36619908 |
| | Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery | Q36676398 |
| | Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study | Q37074678 |
| | Continuing medical education effect on clinical outcomes: effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines | Q37407617 |
| | Practices to prevent venous thromboembolism: a brief review. | Q37599535 |
| | Newer anticoagulants in 2009. | Q37617159 |
| | Review of thromboembolic prophylaxis in patients attending Cork University Hospital | Q38089625 |
| | Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events. | Q38095855 |
| | Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study | Q38497226 |
| | Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery | Q39638109 |
| | Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial | Q42973554 |
| | Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials | Q43674942 |
| | Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. | Q44114570 |
| | Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant | Q44186794 |
| | Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease | Q44393081 |
| | The AVAIL ME study: a multinational survey of VTE risk and prophylaxis | Q44416343 |
| | Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery. | Q44420349 |
| | Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study | Q44471374 |
| | Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients | Q45004028 |
| | Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial | Q45233750 |
| | Low-molecular-weight heparin and mortality in acutely ill medical patients | Q46234341 |
| | Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery | Q47206731 |
| | Implementing NICE guidelines on risk assessment for venous thromboembolism: failure, success and controversy. | Q50883596 |
| | The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, multinational, randomised, open-label, parallel-group comparative study. | Q50944452 |
| | Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. | Q50977960 |
| P921 | main subject | hospitalization | Q3140971 |
| | venous thromboembolism | Q9397786 |
| P304 | page(s) | e20180021 | |
| P577 | publication date | 2019-01-30 | |
| P1433 | published in | Jornal Vascular Brasileiro | Q50521697 |
| P1476 | title | What has changed in venous thromboembolism prophylaxis for hospitalized patients over recent decades: review article | |
| P478 | volume | 18 | |